pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
garetatug rezetecan
garetatug rezetecan [INN]
Gastric Cancer
Jiangsu Hengrui Pharmaceuticals Co Ltd
0 catalysts
pre_registration
garetosmab
Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva)
Inhibin beta A chain
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Marketed
gatifloxacin
Zymaxid (gatifloxacin)
Bacterial Conjunctivitis
$ABBVAbbVie Inc.
catalysts
← prev
page 215 of 271
next →
131
Pain89
Neurology1
0
Phase 3
gavorestat
Neuromuscular Disorders
Applied Therapeutics Inc
0 catalysts
pre_registration
gedatolisib
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
PI3-kinase class ISerine/threonine-protein kinase mTOR
$CELCCelcuity Inc.
0 catalysts
Phase 2
gedeptin
Nasopharyngeal Cancer
$GOVXGeoVax Labs, Inc.
0 catalysts
Marketed
gefitinib
Gefitinib (gefitinib)
Non-Small Cell Lung Cancer
Actavis Laboratories NY Inc (Inactive)
0 catalysts
pre_registration
gefurulimab
Myasthenia Gravis
Alexion Pharmaceuticals Inc
0 catalysts
Phase 1
gemcitabine
Avgemsi (gemcitabine)
Pancreatic Cancer
Continuity Biosciences LLC
0 catalysts
Marketed
gemfibrozil
Gemfibrozil (gemfibrozil)
Hyperlipidemia
Nivagen Pharmaceuticals Inc
0 catalysts
Phase 2
gemlapodect
Stammering (Stuttering)
Noema Pharma AG
0 catalysts
Phase 2
gemogenovatucel-T
Vigil (gemogenovatucel-T)
Endometrial Cancer
Gradalis Inc
0 catalysts
Marketed
gemtuzumab ozogamicin
Mylotarg (gemtuzumab ozogamicin)
Refractory Acute Myeloid Leukemia
$PFEPFIZER INC
0 catalysts
Phase 2
genistein
Pulmonary Fibrosis
Humanetics Corp
0 catalysts
Marketed
gentamicin sulfate
Gentamicin Sulfate (gentamicin sulfate)
Bacterial Blepharoconjunctivitis
Fera Pharmaceuticals LLC
0 catalysts
Preclinical
gentulizumab
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Changchun High-Tech Industry Group Co Ltd
0 catalysts
Marketed
gepirone hydrochloride ER
Exxua (gepirone hydrochloride)
Major Depressive Disorder
Fabre-Kramer Pharmaceuticals Inc
0 catalysts
Phase 2
gilavebexagene anvuparvovec
Tay-Sachs Disease
University of Massachusetts
0 catalysts
Phase 3
gildeuretinol acetate
Juvenile Macular Degeneration (Stargardt Disease)
Alkeus Pharmaceuticals Inc
0 catalysts
Marketed
gilteritinib fumarate
Xospata (gilteritinib fumarate)
Refractory Acute Myeloid Leukemia
Astellas Pharma US Inc
0 catalysts
Phase 1
gintemetostat tartrate
Refractory Multiple Myeloma
K36 Therapeutics Inc
0 catalysts
pre_registration
giredestrant
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Estrogen receptor
Genentech Inc
0 catalysts
Marketed
givinostat hydrochloride
Duvyzat (givinostat hydrochloride)
Polycythemia Vera
Histone deacetylase
Italfarmaco SpA
0 catalysts
Marketed
givosiran
Givlaari (givosiran)
Acute Intermittent Porphyria
$ALNYALNYLAM PHARMACEUTICALS, INC.
0 catalysts
Marketed
glacial acetic acid
Acetic Acid (ACETIC ACID)
Otitis Externa
Sciegen Pharmaceuticals Inc
0 catalysts
Marketed
glasdegib
Daurismo (glasdegib)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$PFEPFIZER INC
0 catalysts
Phase 2
glatiramer acetate ER
glatiramer acetate
Primary Progressive Multiple Sclerosis (PPMS)
Mapi Pharma Ltd
0 catalysts
Phase 2
glecirasib
glecirasib [INN]
Non-Small Cell Lung Cancer
Jacobio Pharmaceuticals Group Co Ltd
0 catalysts
Phase 3
glenzocimab
Acute Ischemic Stroke
Platelet glycoprotein VI
Acticor Biotech SAS
0 catalysts
Marketed
glimepiride
Glimepiride (glimepiride)
Type 2 Diabetes
Carlsbad Technology Inc
0 catalysts